Data on Combo Therapy for Multiple Myeloma to Be Presented by PharmaMar at ASCO Meeting
Positive data for the Phase 1 trial of PharmaMar’s plitidepsin combined with bortezomib and dexamethasone for the treatment of relapsed and/or refractory multiple…